欢迎来到范德生物BIOFOUNT
范德生物中国

中文范德生物中文语言

范德生物产品购买购物车
0
搜索
Iobenguane_139755-80-9_产品详情
139755-80-9
  • names:

    2-[(3-iodophenyl)methyl]guanidine

  • CAS号:

    139755-80-9

    MDL Number:
  • MF(分子式): C8H10IN3 MW(分子量): 275.0896
  • EINECS: Reaxys Number:
  • Pubchem ID: Brand:BIOFOUNT
Iobenguane
货品编码 规格 纯度 价格 (¥) 现价(¥) 特价(¥) 库存描述 数量 总计 (¥)
快速询价
收起
你想询价的产品
请准确填写您的联系方式,以便为您提供最好的服务。
中文别名 Iobenguane
英文别名 Iobenguane, Adreview, Metaiodobenzylguanidine
CAS号 139755-80-9
Inchi InChI=1S/C8H10IN3/c9-7-3-1-2-6(4-7)5-12-8(10)11/h1-4H,5H2,(H4,10,11,12)
InchiKey PDWUPXJEEYOOTR-UHFFFAOYSA-N
分子式 Formula C8H10IN3
分子量 Molecular Weight 275.0896
溶解度Solubility
性状 Solid powder
储藏条件 Storage conditions Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).
产品说明 Iobenguane(CAS:139755-80-9):仅限应用于工业或者科学研究过程中非医疗目的,不应用于人类或动物的临床诊断以及治过程疗,该产品非药用,非食用。
IntroductionIobenguane is a radiopharmaceutical, used in a scintigraphy method called MIBG scan. Iobenguane is a radiolabeled molecule similar to noradrenaline. It localizes to adrenergic tissue and thus can be used to identify the location of tumors such as phaeochromocytomas and neuroblastomas. With I-131 it can also be used to eradicate tumor cells that take up and metabolize norepinephrine.
Application1
Application2
Application3
警示图
危险性 Warning
危险性警示
安全声明
安全防护
备注
[1]Feola M, Chauvie S, Biggi A, Testa M. Role of (123)I-Iobenguane Myocardial Scintigraphy in Predicting Short-term Left Ventricular Functional Recovery: An Interesting Image. J Clin Imaging Sci. 2015 Oct 30;
5:56. doi: 10.4103/2156-7514.168707. eCollection 2015. PubMed PMID: 26664773; PubMed Central PMCID: PMC4647125.
[3]Chin BB, Kronauge JF, Femia FJ, Chen J, Maresca KP, Hillier S, Petry NA, James OG, Oldan JD, Armor T, Stubbs JB, Stabin MG, Babich JW. Phase-1 clinical trial results of high-specific-activity carrier-free 123I-iobenguane. J Nucl Med. 2014 May;55(5):765-71. doi: 10.2967/jnumed.113.124057. Epub 2014 Mar 13. PubMed PMID: 24627436.
[4]Coleman RE, Stubbs JB, Barrett JA, de la Guardia M, Lafrance N, Babich JW. Radiation dosimetry, pharmacokinetics, and safety of ultratrace Iobenguane I-131 in patients with malignant pheochromocytoma/paraganglioma or metastatic carcinoid. Cancer Biother Radiopharm. 2009 Aug;24(4):469-75. doi: 10.1089/cbr.2008.0584. PubMed PMID: 19694582.
[5] Cortés-Blanco A, Martínez Lázaro R, Vargas Castrillón E. [Authorized specifications for human use in clinical practice of radiopharmaceuticals composed of iobenguane (123I) marketed in Spain]. Rev Esp Med Nucl. 2008 Nov-Dec;27(6):468-74. Spanish. PubMed PMID: 19094909.
5: Hinkle GH, Dura JV, Morosco RS, Nahata MC. Extended stability of iobenguane under simulated clinical conditions. Am J Health Syst Pharm. 2008 Jan 15;65(2):142-4. doi: 10.2146/ajhp070247. PubMed PMID: 18192259.
    对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
        新闻
        抱歉,暂无数据!
        My title page contents